Join ACLA Contact Us Site Map Search      
 
American Clinical Laboratory Association  
Partners in Promoting Health
 
  Printer-friendly Version  
 
Coding
ACLA has worked for years to become a participant in the development and revision of CPT codes for clinical laboratory tests...
 
Coding and Reimbursement of Flow Cytometry
In 2003, the Centers for Medicare and Medicaid Services proposed in the annual...
 
Competitive Bidding Laboratory Services
The American Clinical Laboratory Association strongly opposes any effort to impose competitive bidding arrangements for diagnostic laboratory payments under Part B of Medicare or state Medicaid programs...
 
"Condo" Labs
Recent regulatory changes affecting the billing of anatomical pathology services, highly complex diagnostic services that are an important factor in detecting the presence of cancer and other diseases, have fueled the establishment of new types of abusive arrangements...
 
Co-Payments
Federal and state proposals to create co-payments with Medicare and Medicaid programs...
 
Oversight of Laboratory Developed Tests
For several years, FDA officials have indicated they are reconsidering the exemption for in-house developed laboratory tests, which exempts most laboratory-developed tests from FDA oversight and regulation...
 
Fraud and Abuse
ACLA is active on a variety of issue areas within healthcare fraud and abuse.
 
Health Care Information Technology
Increasingly, clinical laboratories are using information technology (IT) innovations to improve patient care, as well as to promote the highest level of efficiency and affordability...
 
Medically Unlikely Edits (MUEs)

CMS, working through a National Correct Coding Initiative (NCCI) contractor, has proposed maximum allowable number of units of service per patient, per day referred to as Medically Unbelievable Edits (MUEs). Unlike some NCCI edits, MUEs cannot be bypassed with NCCI-associated modifiers.

 
OIG Proposed Rule on Excessive Charges
On September 15, 2003, the HHS Office of the Inspector General (OIG) proposed regulations providing guidance on the application of Medicare and Medicaid program exclusion authority for submitting claims containing excessive charges...
 
Public Health
ACLA has become increasingly involved with public health issues over the past few years. Bioterrorism (including the attacks in New York on 9/11, and the use of anthrax as a biological weapon), and emerging infectious disease threats (e.g. SARS, West Nile Virus) resulted in ACLA meeting with HHS Secretary Tommy G. Thompson...
 
Reimbursement for Laboratory Services
Prior to 1984, Medicare reimbursement for laboratory services was paid on a reasonable charge basis, and 80 percent of laboratory services were billed by physicians. A significant share of lab services was performed by independent laboratories that billed physicians who in turn billed Medicare...
 
State Issues
ACLA is active on a variety of state laboratory issues.
 
The Value of Laboratory Services
Clinical laboratory testing plays an essential part in the delivery of quality health care. Laboratory tests provide physicians with objective data needed to promptly diagnose and effectively treat and monitor disease...
 

 

back to top